Services
Corporate Health Solutions
Locations
Health Corner
Investor Relations
About Us

|

Directors' Profile

Executive Directors

 

Dr. SUN Yiu Kwong

Dr. SUN Yiu Kwong (孫耀江), is a founding member of the Group and the Chairman and Chief Executive Officer of the Company. He was appointed as an Executive Director of the Company in 2015. He is primarily responsible for the overall formulation, supervision and guidance of business strategies, planning and development of the Group. He is the Chairman of the Nomination Committee of the Company. Dr. Sun is also a director of various members of the Group.

With over 42 years of experience in family medicine practice, Dr. Sun is a Founder Fellow of the Hong Kong College of Family Physicians. He is a Clinical Associate Professor (Honorary) in Family Medicine at the Chinese University of Hong Kong and a Honorary Clinical Assistant Professor in Family Medicine at the University of Hong Kong. Dr. Sun is one of the pioneer Hong Kong doctors to participate in the healthcare development and training of medical professionals in the PRC. With his wealth of experience in the PRC, in particular his involvement and exposure in the training programmes of various institutions, he plays a leading role in the strategic planning and development of the Group’s healthcare business in the PRC.

Dr. Sun is the father of Dr. Michael Sun and the father-in-law of Mr. Patrick Tsang, both of whom are executive directors of the Company. He is the sole shareholder and a director of East Majestic Group Limited. He is also the sole shareholder and director of EM Team Limited.

He obtained a Bachelor of Medicine, Bachelor of Surgery from the University of Hong Kong in November 1967 and became a Fellow of the Hong Kong College of General Practitioners in September 1987 and a Fellow of the Hong Kong Academy of Medicine in the specialty of Family Medicine in December 1993. He was also registered as a specialist in Family Medicine in March 1998.
 

Ms. KWOK Cheuk Kwan, Jacquen

Ms. KWOK Cheuk Kwan, Jacquen (郭卓君), is the Managing Director of the Company. She was appointed as executive director of the Company in 2015. She is responsible for the overall management and business development of the Group and initiating and leading business projects in collaboration with medical insurance companies and corporate customers. Ms. Kwok is also responsible for developing the management team with a view to enhancing operational efficiency and expanding the Group’s business activities. Ms. Kwok is one of the key members in establishing the administration arm of the Group. She has over 22 years of experience in health schemes management and providers network administration to support the healthcare plan’s implementation in the Group’s network. She is actively involved in developing the infrastructure of the Group such as information technology platforms and medical network facilities. Ms. Kwok is also a director of various companies of the Group.

Ms. Kwok obtained a Bachelor of Arts in International Business Studies (Hons) from the City University of Hong Kong in November 1991 and obtained a Bachelor of Laws from Peking University in July 1996. She also obtained a Master of Science in Management (Health Services Management) from the Hong Kong Polytechnic University in November 2003.
 

Mr. TSANG On Yip, Patrick

Mr. TSANG on Yip, Patrick (曾安業), was appointed as an executive director of the Company in 2015. He is a member of the Remuneration Committee of the Company. Mr. Tsang is primarily responsible for providing strategic directions on co-operations with different business stakeholders in China and globally. He is the Chief Executive Officer and a director of Chow Tai Fook Enterprises Limited. He is also a director of Healthcare Ventures Holdings Limited, a wholly owned subsidiary of CTFE and a substantial shareholder of the Company. Mr. Tsang has over 22 years of international capital markets experience, and was previously managing director, head of Asia Fixed Income Capital Markets at Deutsche Bank AG, Hong Kong Branch, where he worked from 2003 to 2012.

Mr. Tsang is an executive director of Melbourne Enterprises Limited (stock code: 158), a non-executive director of Integrated Waste Solutions Group Holdings Limited (stock code: 923) and a non- executive director of Greenheart Group Limited (stock code: 94), all being companies listed on the Main Board of the Hong Kong Stock Exchange. He was also appointed as a non-executive director of i-Cable Communications Limited (stock code: 1097) on 15 September 2017.

Mr. Tsang is the son-in-law of Dr. Sun Yiu Kwong, the Chairman, Chief Executive Officer of the Company and an executive director of the Company and the brother-in-law of Dr. Michael Sun, an executive director of the Company.

Mr. Tsang obtained a Bachelor of Arts in Economics from Columbia College of Columbia University in New York, USA in May 1994.
 

Dr. SUN Man Kin, Michael

Dr. SUN Man Kin, Michael (孫文堅), was appointed as an executive Director of the Company in 2015. He is a specialist in Radiology and is responsible for expanding the global imaging business of the Company as well as building the physician networks. Dr. Michael Sun has over 12 years of experience in medicine and has been the Chief Radiologist of the Group since July 2012. He is currently a radiologist, a director and a shareholder of ProCare Medical Imaging and Laboratory Centre Limited, a non-wholly owned subsidiary of the Company. He is also a consultant radiologist at Causeway Bay MRI Centre. Dr. Sun is also a director of various members of the Group.

Dr. Michael Sun is the son of Dr. Sun Yiu Kwong, the Chairman, Chief Executive Officer of the Company and executive director of the Company and the brother-in-law of Mr. Tsang On Yip, Patrick, an executive Director. He is also a director of East Majestic Group Limited.

Dr. Michael Sun obtained a Bachelor of Medicine, Bachelor of Surgery from the University of Hong Kong in December 2002. He became a Fellow of the Royal College of Radiologist in October 2007 and a Fellow of the Hong Kong College of Radiologists in October 2010. He also became a Fellow of the Hong Kong Academy of Medicine in the specialty of Radiology in June 2010.
 

Mr. LEE Kar Chung, Felix

Mr. LEE Kar Chung, Felix (李家聰), was appointed as an executive director of the Company in 2015. He is responsible for corporate development, international operations and merger and acquisitions for the Group. Mr. Lee joined the Group as director, corporate development and strategy of the Group in September 2014. He is currently a Senior Vice President of CTFE with responsibilities in making investments in the healthcare sector in Asia and globally and a director of Healthcare Ventures Holdings Limited, a wholly owned subsidiary of CTFE, a substantial shareholder of the Company. Mr. Lee is also an independent non-executive director of China Resources Phoenix Healthcare Holdings Company Limited (stock code: 1515), a substantial shareholder of the Company. Mr. Lee is also a director of various members of the Group. He has over 12 years of experience in law and finance. He was an associate with the law firm Freshfields Bruckhaus Deringer before he left in February 2008 to join UBS AG, Hong Kong branch as an analyst in the investment banking department until January 2009. He then joined the investment banking department of Deutsche Bank AG, Hong Kong branch and last held the position of director in the Corporate Advisory Group, where he worked from January 2009 to August 2014.

Mr. Lee obtained a Bachelor of Laws from the London School of Economics and Political Sciences and a Postgraduate Certificate in Laws from the University of Hong Kong in July 2003 and June 2004, respectively. He is a solicitor of the High Court of Hong Kong since September 2007 and a solicitor (non-practising) in the Senior Courts of England and Wales since February 2013.
 

Dr. LEE Pak Cheung, Patrick

Dr. Lee Pak Cheung, Patrick (李柏祥), joined the Group in 2003 and was appointed as executive director of the Company on 28 February 2018.  He was appointed as the Dental Director for the Group in 2014, primarily responsible for supervising the dental practice of the Group and advising on the continuing training of dental professionals and development of clinical and professional services.  Dr. Patrick Lee is one of the major contributor in the Group’s dental centre chain, he keeps an active practice to nurture and inspire his dental colleagues.  Dr. Patrick Lee also performs a key role in business development and quality assurance in the Group’s central centre chain. Dr. Patrick Lee obtained a Bachelor of Dental Surgery from the University of Hong Kong in 1988.  He became a member of faculty of general dental practitioners (UK) of the Royal College of Surgeons of England in 1995 and a member in general dental surgery of the Royal College of Surgeons of Edinburgh in 1997.  In 1999, he became a Fellow of the Royal Australasian College of Dental Surgeons.  In 2007, he was granted a Diploma of Membership in General Dentistry by the College of Dental Surgeons of Hong Kong.

 

Independent Non-Executive Directors

 

Mr. LEE Luen-Wai, John BBS JP

Mr. LEE Luen-Wai, John BBS JP (李聯偉), was appointed as an independent non-executive director of the Company in 2015. He is the chairman of Audit Committee and a member of the Nomination Committee of the Company. Mr. Lee is an independent non-executive director of New World Development Company Limited (stock code: 17), an associate of CTFE. Mr. Lee is also the managing director and chief executive officer of Lippo Limited (stock code: 226), an executive director and the chief executive officer of both Lippo China Resources Limited (stock code: 156) and Hongkong Chinese Limited (stock code: 655), all being companies listed on the Main Board of the Hong Kong Stock Exchange. He was also appointed as a non-executive non-independent chairman of Healthway Medical Corporation Limited, a company listed on the Catalist Board of the Singapore Exchange Securities Trading Limited and an investee company of Lippo China Resources Limited, on 2 August 2017. He resigned as an independent non-executive director of New World China Land Limited (former stock code: 917), an associate of CTFE, with effect from 1 September 2016 after the listing of its shares on the Hong Kong Stock Exchange had been withdrawn on 4 August 2016 following its privatisation.

Mr. Lee is a Fellow of The Institute of Chartered Accountants in England and Wales, the Association of Certified Accountants and the Hong Kong Institute of Certified Public Accounts. He was a partner of Pricewaterhouse (now known as PricewaterhouseCoopers) in Hong Kong and has extensive experience in corporate finance and capital markets. Mr. Lee is an Honorary Fellow of the City University of Hong Kong and a Justice of Peace in Hong Kong and an awardee of the Bronze Bauhinia Star by the Government of the Hong Kong Special Administrative Region.

Mr. Lee is active in public service. Over the years, he has served as a member or chairman of different government boards and committees in Hong Kong, including a member of the Hong Kong Hospital Authority and the chairman of the Hospital Governing Committee of the Queen Elizabeth Hospital.  Mr. Lee retired as a member of Appeal Boards Panel (Education) on 31 December 2017 and a Trustee of the Board of the Hospital Authority Provident Fund Scheme (“HAPFS”) on 18 November 2017.  He retains as the Chairman of the Investment Committee of the HAPFS.  Mr. Lee has been appointed as Chairman of the Hospital Governing Committee of Hong Kong Children’s Hospital with effect from 1 April 2018.
 

Dr. LI Kwok Tung, Donald SBS JP

Dr. LI Kwok Tung, Donald SBS JP (李國棟) was appointed as an independent non-executive director of the Company in 2015. He is the chairman of the Remuneration Committee and a member of the Audit Committee and the Nomination Committee of the Company. Dr. Li is a specialist in Family Medicine in private practice in Hong Kong. He is the immediate past President of the Hong Kong Academy of Medicine, the President Elect of the World Organisation of Family Doctors (WONCA) and Censor of the Hong Kong College of Family Physicians.

Dr. Li obtained a Bachelor of Arts from Cornell University, USA, and a Bachelor of Medicine and a Bachelor of Surgery from the University of Hong Kong in June 1975 and November 1980, respectively. He became a Fellow of the Hong Kong College of General Practitioners in September 1987, Fellow of the Hong Kong Academy of Medicine in December 1993, Honorary Fellow of  the Hong Kong College of Dental Surgeons in August 2004, Honorary Fellow of the Royal Australian College of General Practitioners in September 2005, Honorary Fellow of the Hong Kong College of  Family Physicians in May 2007, Fellow of the Faculty of Public Health of the Royal Colleges of Physicians of the United Kingdom in February 2010, Honorary Fellow of the Academy of Family Physicians of Malaysia in April 2011, Registered Mainland China Medical Practitioner in April 2013, Honorary Fellow of the American College of Physicians in November 2012, Honorary Fellow of the Royal College of Physicians of Thailand in April 2013, Fellow of the Academy of Medicine, Singapore, in August 2013, Honorary Fellow of the Royal College of Physicians of Ireland in October 2014 and Honorary Fellow of the Royal College of General Practitioners in November 2014.

He served as Member of Council of Cornell University.  He is a Clinical Associate Professor (honorary) in Family Medicine at the Chinese University of Hong Kong, Honorary Professor of the Li Ka Shing Faculty of Medicine of the University of Hong Kong.

Dr. Li is the Director of the Hong Kong St. John Ambulance Association and member of Hong Kong St. John Ambulance council. He is the chairman of Bauhinia Foundation Research Centre and also the chairman of the Hong Kong Sheng Kung Hui Welfare Council and serves as a member on the committee of the Community Care Fund Task Force. He is an Honorary Steward of the Hong Kong Jockey Club. He is the Adjunct Associate Professor of the Faculty of Health Science of Macau University of Science and Technology. He is the Honorary Adviser of The Hong Kong Award for Young People. He is also a member of the steering committee on Strategic Review on Healthcare Manpower Planning and Professional Development, the Health and Medical Development Advisory Committee of Food and Health Bureau of the Government of Hong Kong, the member of the committee on Promotion of Organ Donation of Food and Health Bureau of the Government of Hong Kong as well as the member of High Level Steering Committee on Antimicrobial Resistance of Food and Health Bureau of the Government of Hong Kong.  On 13 December 2017, Dr. Li was appointed as an independent non-executive director of C-MER Eye Care Holdings Limited (stock code: 3309).
 

Mr. YEUNG Wing Sun, Mike

Mr. YEUNG Wing Sun, Mike (楊榮燊), was appointed as an independent non-executive director of the Company in 2015. He is a member of the Audit Committee and the Remuneration Committee of the Company. Mr. Yeung is an independent non- executive director and a member of the audit committee and nomination committee of Hong Kong Shanghai Alliance Holdings Limited (stock code: 1001), a company listed on the Main Board of the Hong Kong Stock Exchange. He has over 40 years’ working experience in banking industry. Mr. Yeung began his career with the HSBC Group in 1972 and advanced himself in the organisation by taking up different positions under various business streams including personal banking, sales and marketing, branch operation and trade service. In 2001, Mr. Yeung was relocated to Shanghai and took up the role of branch manager of HSBC Shanghai. In June 2006, he was seconded to Hang Seng Bank (China) Limited and appointed   as the head of personal financial services and wealth management. He assumed the role of Deputy Chief Executive and Head of Retail Banking and Wealth Management in May 2007. Mr. Yeung retired from HSBC Group in January 2014. Mr. Yeung is a member of the Honorary President of Hong Kong Chamber of Commerce in Shanghai. He was awarded the “Magnolia Gold Award” presented by the Shanghai Municipal government. Mr. Yeung was also awarded a Professional Diploma in Company Direction by The Hong Kong Institute of Directors in 2017.  Mr. Yeung retired as a member of Chinese People’s Political Consultative Conference Committee in Shanghai since January 2018.

 


//